UltraTech Cement Q1 Preview: Analysts Anticipate Strong Growth Amid Industry Tailwinds

1 min read     Updated on 20 Jul 2025, 02:31 PM
scanxBy ScanX News Team
whatsapptwittershare
Overview

UltraTech Cement, India's largest cement producer, is expected to report robust growth in its upcoming quarterly results. Analysts project 19% revenue growth to Rs 21,506.00 crore and 20.5% EBITDA growth to Rs 4,408.65 crore. Volume growth forecasts range from 7% to 18% YoY, supported by capacity expansions and acquisitions. Jefferies anticipates 33-45% YoY EBITDA growth. The positive outlook is driven by government infrastructure initiatives and strong housing demand, though challenges like early monsoon and input cost volatility remain.

14547675

*this image is generated using AI for illustrative purposes only.

UltraTech Cement , India's largest cement producer with a staggering 192.26 MTPA capacity, is poised to unveil its quarterly results, with analysts projecting robust growth across key metrics. The cement giant's performance is expected to reflect the broader positive sentiment in the Indian cement industry, driven by government infrastructure initiatives and strong housing demand.

Revenue and EBITDA Projections

According to Bloomberg estimates, UltraTech Cement is anticipated to report:

  • Revenue growth of 19% to Rs 21,506.00 crore
  • EBITDA growth of 20.5% to Rs 4,408.65 crore

These projections underscore the company's strong market position and operational efficiency in a growing market.

Volume Growth and Capacity Expansion

Analysts remain bullish on UltraTech Cement's prospects:

  • Citi projects 9-14% volume growth for FY26
  • Capacity addition of 12.4mt expected
  • Morgan Stanley forecasts 7% volume growth
  • Nuvama anticipates 18% YoY grey cement volume growth, boosted by acquisitions including India Cements

EBITDA Expectations

Jefferies has set high expectations for UltraTech's performance, forecasting a remarkable 33-45% YoY EBITDA growth. This projection aligns with the overall positive outlook for the company's financial health and market position.

Analyst Recommendations

Several prominent financial institutions have expressed confidence in UltraTech Cement:

  • Elara Capital and Jefferies have named UltraTech as a top pick in the sector
  • Multiple analysts maintain a bullish stance on the stock

Industry Outlook

The Indian cement industry is poised for robust growth, primarily driven by:

  1. Government infrastructure spending
  2. Strong housing demand

However, potential challenges loom on the horizon:

  • Early onset of monsoon may impact construction activities
  • Input cost volatility could affect pricing strategies

Conclusion

As UltraTech Cement prepares to release its quarterly results, the market eagerly anticipates strong performance across key metrics. The company's strategic acquisitions, capacity expansions, and favorable industry tailwinds position it well for continued growth. However, investors and analysts will be keenly watching how the company navigates potential challenges such as monsoon impacts and input cost fluctuations in the coming quarters.

Historical Stock Returns for UltraTech Cement

1 Day5 Days1 Month6 Months1 Year5 Years
+0.63%+0.49%+9.85%+17.90%+9.22%+225.55%
UltraTech Cement
View in Depthredirect
like17
dislike

UltraTech Cement to Announce Q1 FY2026 Results on July 21

1 min read     Updated on 19 Jul 2025, 06:15 PM
scanxBy ScanX News Team
whatsapptwittershare
Overview

UltraTech Cement, India's largest cement producer, will release its Q1 FY2026 results on July 21. The company has scheduled a board meeting to approve standalone and consolidated unaudited financial results for the quarter ended June 30, 2025. An earnings call is set for 4 p.m. on the same day. The trading window for designated persons is closed from July 1 to July 23. UltraTech Cement has a production capacity of 192.26 million tonnes per annum. In the previous quarter, the company reported a 9.57% increase in consolidated net profit and a 12.70% rise in total income. The company's stock has shown strong performance, with a 9.44% gain over the past month and a 17.63% increase over six months.

14474738

*this image is generated using AI for illustrative purposes only.

UltraTech Cement , India's largest cement producer, is set to reveal its first quarter results for the fiscal year 2026 on July 21. The Aditya Birla Group company has scheduled a board meeting to approve both standalone and consolidated unaudited financial results for the quarter ended June 30, 2025.

Key Highlights

  • Results Announcement: July 21, 2025
  • Earnings Call: Scheduled for 4 p.m. on the same day
  • Trading Window: Closed for designated persons from July 1 to July 23

Company Overview

UltraTech Cement boasts an impressive production capacity of 192.26 million tonnes per annum, solidifying its position as the leading cement manufacturer in India.

Recent Performance

In the previous quarter, UltraTech Cement demonstrated strong financial performance:

Metric Value Year-on-Year Change
Consolidated Net Profit 2474.79 9.57%
Total Income 23165.45 12.70%

Stock Performance

UltraTech Cement's shares have shown robust growth in recent months:

  • 1-Month Gain: 9.44%
  • 6-Month Gain: 17.63%

The stock closed at 12498.00 on Friday, reflecting investor confidence in the company's performance.

As the cement industry leader prepares to unveil its Q1 FY2026 results, stakeholders will be keenly watching for insights into the company's performance amidst evolving market conditions. The upcoming earnings call is expected to provide valuable information on UltraTech Cement's strategies and outlook for the remainder of the fiscal year.

Historical Stock Returns for UltraTech Cement

1 Day5 Days1 Month6 Months1 Year5 Years
+0.63%+0.49%+9.85%+17.90%+9.22%+225.55%
UltraTech Cement
View in Depthredirect
like19
dislike
More News on UltraTech Cement
Explore Other Articles
Sagar Cements Rebounds with ₹7.5 Crore Q1 Profit, Revenue Surges to ₹671 Crore just now
CIE Automotive Reports Mixed Q1 Results: Revenue Growth Amid Profit Decline 8 minutes ago
Shukra Pharmaceuticals Expands Portfolio with 28 New Medical Device Distribution Partnerships 28 minutes ago
12,577.00
+79.00
(+0.63%)